These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]
11. [Early detection and control of risk factors in diabetic nephropathy]. Fernández López MT; Isidro San Juan ML; Cordido F An Med Interna; 1998 Nov; 15(11):600-5. PubMed ID: 9882860 [TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: early detection, prevention and management. Maher JF Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042 [TBL] [Abstract][Full Text] [Related]
13. Controversies on the prevention of diabetic nephropathy. Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of diabetic nephropathies]. Arakawa M; Suzuki Y Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1642-7. PubMed ID: 7798763 [No Abstract] [Full Text] [Related]
15. Diabetic nephropathy: common questions. Thorp ML Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688 [TBL] [Abstract][Full Text] [Related]